{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:35:31Z","timestamp":1783110931021,"version":"3.54.6"},"reference-count":81,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372069"],"award-info":[{"award-number":["82372069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072041"],"award-info":[{"award-number":["82072041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e29866","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T03:54:04Z","timestamp":1713326044000},"page":"e29866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Enhancing the therapeutic impact of sublethal radiofrequency hyperthermia in malignant solid tumor treatment"],"prefix":"10.1016","volume":"10","author":[{"given":"Jiayun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuansheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/bjs.9960","article-title":"Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas","volume":"103","author":"Kim","year":"2016","journal-title":"Br. J. Surg."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29866_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ccm.2020.02.002","article-title":"Alternatives to surgery for early-stage non-small cell lung cancer: thermal ablation","volume":"41","author":"Quirk","year":"2020","journal-title":"Clin. Chest Med."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29866_bib3","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.3892\/ol.2016.5267","article-title":"Safety and effectiveness of percutaneous radiofrequency ablation in early stage renal cell carcinoma","volume":"12","author":"Liu","year":"2016","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29866_bib4","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1016\/j.ejrad.2012.05.007","article-title":"Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation","volume":"81","author":"Lin","year":"2012","journal-title":"Eur. J. Radiol."},{"issue":"41","key":"10.1016\/j.heliyon.2024.e29866_bib5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113028118","article-title":"Interventional real-time optical imaging guidance for complete tumor ablation","volume":"118","author":"Kan","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29866_bib6","doi-asserted-by":"crossref","first-page":"e990","DOI":"10.1634\/theoncologist.2018-0337","article-title":"Radiofrequency ablation and Microwave ablation in liver tumors: an Update","volume":"24","author":"Izzo","year":"2019","journal-title":"Oncol."},{"key":"10.1016\/j.heliyon.2024.e29866_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejrad.2018.01.009","article-title":"Efficacy and safety of radiofrequency ablation for lung cancers: a systematic review and meta-analysis","volume":"100","author":"Li","year":"2018","journal-title":"Eur. J. Radiol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29866_bib8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00120-018-0671-x","article-title":"[Percutaneous CT-guided radiofrequency ablation for small renal masses : a retrospective, single center data analysis]","volume":"57","author":"Hei\u00dfler","year":"2018","journal-title":"Urologe"},{"key":"10.1016\/j.heliyon.2024.e29866_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2018.02.024","article-title":"Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy","volume":"421","author":"Zhao","year":"2018","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29866_bib10","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hep.31766","article-title":"Insufficient radiofrequency ablation promotes hepatocellular carcinoma metastasis through N6-Methyladenosine mRNA methylation-dependent mechanism","volume":"74","author":"Su","year":"2021","journal-title":"Hepatology"},{"issue":"6 Pt B","key":"10.1016\/j.heliyon.2024.e29866_bib11","first-page":"E281","article-title":"Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model","volume":"110","author":"Kroeze","year":"2012","journal-title":"BJU Int."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29866_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002228","article-title":"ICAM-1 activates platelets and promotes endothelial permeability through VE-cadherin after insufficient radiofrequency ablation","volume":"8","author":"Kong","year":"2021","journal-title":"Adv. Sci."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29866_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294263","article-title":"HSP70 via HIF-1 \u03b1 SUMOylation inhibits ferroptosis inducing lung cancer recurrence after insufficient radiofrequency ablation","volume":"18","author":"Peng","year":"2023","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29866_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005619","article-title":"Enhanced efficacy of direct immunochemotherapy for hepatic cancer with image-guided intratumoral radiofrequency hyperthermia","volume":"10","author":"Kan","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.heliyon.2024.e29866_bib15","article-title":"Image-Guided peri-tumoral radiofrequency hyperthermia-enhanced direct chemo-destruction of hepatic tumor margins","volume":"11","author":"Chen","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29866_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/02656738609012389","article-title":"Tumour microcirculation as a target for hyperthermia","volume":"2","author":"Reinhold","year":"1986","journal-title":"Int. J. Hyperther."},{"key":"10.1016\/j.heliyon.2024.e29866_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/748290","article-title":"Hyperthermia differently affects connexin 43 expression and gap junction permeability in skeletal myoblasts and HeLa cells","volume":"2014","author":"Antanavi\u010di\u016bt\u0117","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29866_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1667\/0033-7587(2000)154[0196:LCHIVC]2.0.CO;2","article-title":"Local 42 degrees C hyperthermia improves vascular conductance of the R3230Ac rat mammary adenocarcinoma during sodium nitroprusside infusion","volume":"154","author":"Meyer","year":"2000","journal-title":"Radiat. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29866_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/02656736.2013.790563","article-title":"A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatment","volume":"29","author":"Landon","year":"2013","journal-title":"Int. J. Hyperther."},{"key":"10.1016\/j.heliyon.2024.e29866_bib20","article-title":"Image-Guided radiofrequency hyperthermia (RFH)-Enhanced direct chemotherapy of hepatic tumors: the underlying biomolecular mechanisms","volume":"10","author":"Qian","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e29866_bib21","first-page":"3619","article-title":"Intratumoral radiofrequency hyperthermia-enhanced chemotherapy of liposomal doxorubicin on hepatocellular carcinoma","volume":"10","author":"Gao","year":"2018","journal-title":"Am J Transl Res"},{"issue":"5933","key":"10.1016\/j.heliyon.2024.e29866_bib22","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29866_bib23","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.18632\/oncotarget.12295","article-title":"Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer","volume":"8","author":"Bai","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29866_bib24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1148\/radiol.13130866","article-title":"Intrabiliary RF heat-enhanced local chemotherapy of a cholangiocarcinoma cell line: monitoring with dual-modality imaging--preclinical study","volume":"270","author":"Zhang","year":"2014","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e29866_bib25","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.7150\/thno.10006","article-title":"Radiofrequency heat-enhanced chemotherapy for breast cancer: towards interventional molecular image-guided chemotherapy","volume":"4","author":"Zhou","year":"2014","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1148\/radiol.2016152281","article-title":"Orthotopic esophageal cancers: intraesophageal hyperthermia-enhanced direct chemotherapy in rats","volume":"282","author":"Shi","year":"2017","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29866_bib27","first-page":"7250","article-title":"Radiofrequency heat-enhanced direct intratumoral chemotherapy for prostate cancer","volume":"14","author":"Wu","year":"2017","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41392-022-01286-3","article-title":"Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial","volume":"8","author":"Zhong","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"25","key":"10.1016\/j.heliyon.2024.e29866_bib29","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1200\/JCO.19.00075","article-title":"Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIia-N2 EGFR-mutant non-small-cell lung cancer (EMERGING-CTONG 1103): a randomized phase II study","volume":"37","author":"Zhong","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/02656736.2010.500645","article-title":"The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study","volume":"27","author":"Shen","year":"2011","journal-title":"Int. J. Hyperther."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29866_bib31","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib32","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2022.2157498","article-title":"Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer","volume":"40","author":"Brummelhuis","year":"2023","journal-title":"Int. J. Hyperther."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29866_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1-3 Years of maintenance Bacillus calmette-gu\u00e9rin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29866_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/cancers13030377","article-title":"Long-term experience with radiofrequency-induced hyperthermia combined with intravesical chemotherapy for non-muscle invasive bladder cancer","volume":"13","author":"Brummelhuis","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29866_bib35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/02656736.2016.1140232","article-title":"Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer","volume":"32","author":"van Valenberg","year":"2016","journal-title":"Int. J. Hyperther."},{"key":"10.1016\/j.heliyon.2024.e29866_bib36","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2016.01.006","article-title":"Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus Bacillus calmette-gu\u00e9rin for adjuvant treatment of patients with intermediate- and high-risk non-muscle-invasive bladder cancer","volume":"69","author":"Arends","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.heliyon.2024.e29866_bib37","first-page":"2299","article-title":"Hyperthermia combined with chemotherapy for patients with residual or recurrent oesophageal cancer after definitive chemoradiotherapy","volume":"35","author":"Nishimura","year":"2015","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29866_bib38","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/02656736.2015.1032370","article-title":"Cell death, perfusion and electrical parameters are critical in models of hepatic radiofrequency ablation","volume":"31","author":"Hall","year":"2015","journal-title":"Int. J. Hyperther."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29866_bib39","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jbiomech.2015.02.023","article-title":"Analysis and analytical characterization of bioheat transfer during radiofrequency ablation","volume":"48","author":"Wang","year":"2015","journal-title":"J. Biomech."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29866_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/02656736.2015.1006268","article-title":"A new mechanism of thermal sensitivity for rapid drug release and low systemic toxicity in hyperthermia and thermal ablation temperature ranges","volume":"31","author":"Dabbagh","year":"2015","journal-title":"Int. J. Hyperther."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29866_bib41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cam4.431","article-title":"A novel strategy of radiofrequency hyperthermia (neothermia) in combination with preoperative chemoradiotherapy for the treatment of advanced rectal cancer: a pilot study","volume":"4","author":"Shoji","year":"2015","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29866_bib42","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1021\/am507898z","article-title":"Radiofrequency-triggered tumor-targeting delivery system for theranostics application","volume":"7","author":"Wang","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29866_bib43","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.7314\/APJCP.2014.15.5.2359","article-title":"Effects of thermotherapy on Th1\/Th2 cells in esophageal cancer patients treated with radiotherapy","volume":"15","author":"Hong","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"18","key":"10.1016\/j.heliyon.2024.e29866_bib44","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.3390\/cancers14184383","article-title":"The current role of stereotactic body radiation therapy (SBRT) in hepatocellular carcinoma (HCC)","volume":"14","author":"Kimura","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29866_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S2468-1253(22)00339-9","article-title":"Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial","volume":"8","author":"Chiang","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e29866_bib46","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29866_bib47","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.ijrobp.2011.03.019","article-title":"Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes","volume":"82","author":"Yoon","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29866_bib48","first-page":"407","article-title":"Analysis of short and long term therapeutic effects of radiofrequency hyperthermia combined with conformal radiotherapy in hepatocellular carcinoma","volume":"21","author":"Dong","year":"2016","journal-title":"J BUON"},{"issue":"23","key":"10.1016\/j.heliyon.2024.e29866_bib49","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1158\/1078-0432.CCR-17-3620","article-title":"The integration of radiotherapy with immunotherapy for the treatment of non-small cell lung cancer","volume":"24","author":"Ko","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijrobp.2008.03.059","article-title":"Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes","volume":"73","author":"Ohguri","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e29866_bib51","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/02656730210146917","article-title":"Effect of hyperthermia combined with external radiation therapy in primary non-small cell lung cancer with direct bony invasion","volume":"18","author":"Sakurai","year":"2002","journal-title":"Int. J. Hyperther."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2012.02.018","article-title":"Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients","volume":"77","author":"Ohguri","year":"2012","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13014-017-0766-3","article-title":"Current controversies in radiotherapy for breast cancer","volume":"12","author":"Krug","year":"2017","journal-title":"Radiat. Oncol."},{"issue":"supplement","key":"10.1016\/j.heliyon.2024.e29866_bib54","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.4103\/jcrt.JCRT_1087_21","article-title":"Radiosensitization effect of radiofrequency hyperthermia in the presence of PEGylated-gold nanoparticles on the MCF-7 breast cancer cells under 6 MeV electron irradiation","volume":"19","author":"Mohammadi","year":"2023","journal-title":"J Cancer Res Ther"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29866_bib55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/02656730110049538","article-title":"Thermoradiotherapy for locally recurrent breast cancer with skin involvement","volume":"17","author":"Hehr","year":"2001","journal-title":"Int. J. Hyperther."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29866_bib56","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jamaoncol.2017.5179","article-title":"Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial","volume":"4","author":"Shrivastava","year":"2018","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29866_bib57","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/02656730010001333","article-title":"A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma","volume":"17","author":"Harima","year":"2001","journal-title":"Int. J. Hyperther."},{"key":"10.1016\/j.heliyon.2024.e29866_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595207","article-title":"Hyperthermia targeting the tumor microenvironment facilitates immune checkpoint inhibitors","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15948-3","article-title":"Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis","volume":"12","author":"Mu\u00f1oz","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29866_bib60","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1002\/cam4.5085","article-title":"Hyperthermia combined with immune checkpoint inhibitor therapy: synergistic sensitization and clinical outcomes","volume":"12","author":"Liu","year":"2023","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29866_bib61","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00262-014-1540-0","article-title":"Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315","volume":"63","author":"Camilio","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29866_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1594555","article-title":"Tumor lysis with LTX-401 creates anticancer immunity","volume":"8","author":"Xie","year":"2019","journal-title":"OncoImmunology"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e29866_bib63","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"24","key":"10.1016\/j.heliyon.2024.e29866_bib64","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.3390\/cancers14246093","article-title":"Interventional oncolytic immunotherapy with LTX-315 for residual tumor after incomplete radiofrequency ablation of liver cancer","volume":"14","author":"Zhou","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e29866_bib65","article-title":"Interventional optical imaging-monitored synergistic effect of radio-frequency hyperthermia and oncolytic immunotherapy","volume":"11","author":"Zheng","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib66","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/02656736.2019.1569731","article-title":"Orthotopic hepatocellular carcinoma: molecular imaging-monitored intratumoral hyperthermia-enhanced direct oncolytic virotherapy","volume":"36","author":"Song","year":"2019","journal-title":"Int. J. Hyperther."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e29866_bib67","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1007\/s00270-022-03210-2","article-title":"Radiofrequency hyperthermia enhances locally delivered oncolytic immuno-virotherapy for pancreatic adenocarcinoma","volume":"45","author":"Li","year":"2022","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29866_bib68","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/14712598.2012.675323","article-title":"Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors","volume":"12","author":"Mesiano","year":"2012","journal-title":"Expet Opin. Biol. Ther."},{"issue":"19","key":"10.1016\/j.heliyon.2024.e29866_bib69","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.3748\/wjg.v19.i19.2956","article-title":"Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma","volume":"19","author":"Wang","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2024.e29866_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.590764","article-title":"Modulated electro-hyperthermia facilitates NK-cell infiltration and growth arrest of human A2058 melanoma in a xenograft model","volume":"11","author":"Vancsik","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e29866_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","article-title":"Immune checkpoint inhibitors: recent progress and potential biomarkers","volume":"50","author":"Darvin","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e29866_bib73","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2018.02.024","article-title":"Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy","volume":"421","author":"Zhao","year":"2018","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29866_bib74","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00432-019-02852-z","article-title":"Insufficient radiofrequency ablation promotes the metastasis of residual hepatocellular carcinoma cells via upregulating flotillin proteins","volume":"145","author":"Zhang","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e29866_bib75","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.7150\/jca.20816","article-title":"Insufficient radiofrequency ablation treated hepatocellular carcinoma cells promote metastasis by up-regulation ITGB3","volume":"8","author":"Zhang","year":"2017","journal-title":"J. Cancer"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e29866_bib76","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00270-020-02505-6","article-title":"CTLA-4 blockade suppresses progression of residual tumors and improves survival after insufficient radiofrequency ablation in a subcutaneous murine hepatoma model","volume":"43","author":"Zhang","year":"2020","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29866_bib77","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/02656736.2016.1229045","article-title":"Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase\/ganciclovir direct intratumoral gene therapy of hepatocellular carcinoma","volume":"33","author":"Wang","year":"2017","journal-title":"Int. J. Hyperther."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e29866_bib78","first-page":"2054","article-title":"Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase\/ganciclovir direct intratumoral gene therapy of esophageal squamous cancers","volume":"6","author":"Shi","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29866_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/02656736.2020.1711973","article-title":"Molecular imaging-monitored radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy for rat orthotopic ovarian cancer","volume":"37","author":"Li","year":"2020","journal-title":"Int. J. Hyperther."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29866_bib80","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1148\/radiol.2018172148","article-title":"Non-small-cell lung cancer: feasibility of intratumoral radiofrequency hyperthermia-enhanced herpes simplex virus thymidine kinase gene therapy","volume":"288","author":"Ji","year":"2018","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29866_bib81","first-page":"502","article-title":"Cholangiocarcinoma: molecular imaging-guided radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus thymidine kinase gene therapy","volume":"8","author":"Jin","year":"2018","journal-title":"Am. J. Cancer Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024058973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024058973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:05:23Z","timestamp":1773767123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024058973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024058973"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29866","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the therapeutic impact of sublethal radiofrequency hyperthermia in malignant solid tumor treatment","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29866","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e29866"}}